Document is current
Any future updates will be listed below
-
Authors
Inoko, Akihito https://orcid.org/0000-0002-6739-2948
Soga, Norihito https://orcid.org/0000-0002-6024-2816
Suzuki, Minako
Kiyono, Tohru https://orcid.org/0000-0002-7360-5567
Ikenouchi, Junichi https://orcid.org/0000-0002-2936-3548
Kojima, Takahiro
Sato, Yoshikatsu https://orcid.org/0000-0002-4967-2698
Saito, Daisuke https://orcid.org/0000-0002-5999-2505
Miyamoto, Tatsuo https://orcid.org/0000-0002-1097-0647
Goshima, Naoki
Ito, Hideaki
Kasai, Kenji https://orcid.org/0000-0001-6566-9483
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP19K06671, JP19K21599, JP24K12500, JP20K16205)
the Japan Agency for Medical Research and Development (JP21gm4010011h0001, JP21gm4010011h0001)
the Takeda Science Foundation
the Astellas Foundation for Research on Metabolic Disorders
the Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University, Nagasaki University, and Fukushima Medical University
the Shinnihon Foundation of Advanced Medical Treatment Research
- License Information
-
More Information
Article History
Received: 9 December 2024
Accepted: 21 March 2025
First Online: 9 April 2025
Declarations
:
: The authors declare no competing interests.
: HMECs and PrECs were purchased from Lonza, who provided the following ethics statement: ‘These cells were isolated from donated human tissue after obtaining permission for their use in research applications by informed consent or legal authorization.’ No further permission was required since we used commercially provided human cells in accordance with the internal regulation of our institutional review board.
